Prothrombin 20210A Allele May Not Be an Independent Risk Factor for Myocardial Infarction

The G->A transition at position 20210 in the prothrombin gene is a genetic risk factor for venous thrombosis. Nevertheless, it is not clear if the prothrombin 20210A allele is also a genetic risk factor for arterial thrombosis. We studied 124 patients with myocardial infarction (MI) and 182 healthy individuals to assess the possible correlation between prothrombin gene polymorphism and MI. In addition, we analyzed 42 MI patients, who were selected as having no other secondary risk factors and who thus have a potential genetic predisposition to infarction. The frequencies of heterozygous carriers of the 20210A polymorphism of the gene (% GA genotype) were calculated as follows: among the 124 patients with MI 3.23%, 42 selected patients 9.53% and among the 46 selected controls 4.35%. The prothrombin 20210A allele was detected by allele specific polymerase chain reaction. We found no correlation between the prothrombin 20210A allele and MI. This study supports the view of that prothrombin 20210A polymorphism is not an independent risk factor for MI.

Anahtar Kelimeler:

Prothrombin 20210A, Myocardial infarction, Heart, Turkey

Prothrombin 20210A Allele May Not Be an Independent Risk Factor for Myocardial Infarction

Keywords:

Prothrombin 20210A, Myocardial infarction, Heart, Turkey,

PDF

___

Redondo M, Watzke Hh, Stucki B et al. Coagulation Factors II, V, VII, and X, Prothrombin Gene 20210G->A Transition, and Factor V Leiden in Coronary Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology 19: 1020-1025, 1999.
Adrissino D, Mannucci PM, Merlini PA et al. Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction. Blood 94: 46-51, 1999.
Arruda VR, Annichino-Bizzacchi JM, Gonçalves MS et al. Prevelance of the Prothrombin Gene Variant (nt20210A) in Venous Thrombosis and Arterial Disease. Thrombosis Haemostasis 78: 1430-1433, 1997.
Hutton RA, Laffen MA. Tuddenham EGD. Normal Haemostasis. Hoffbrand AV, Lewis SM, Tuddenhary EGD, editors. Postgraduate Haematology. Oxford: Butter Heinemann; pp: 568, 1999.
Rogier MB. The Prothrombin 20210 G to A Variation and thrombosis. Hemostasis and Thrombosis 5: 339-342, 1998. 6. Akar N, Mısıroğlu M, Akar E et al. Prothrombin Gene 20210 G-A Mutation in the Turkish Population. American Journal of Hematology 58: 179-180, 1998 7. Renner W, Köppel H, Brodmann M et al. Factor II G20210A Gene Mutations and Peripheral Arterial Occlusive Disease. Thrombosis Haemostasis 83: 20-22, 2000.
Corral J, Gonzalez-Conejero R, Lozano ML et al. The Venous Thrombosis Risk Factor 20210 A Allele of the Prothrombin Gene is not a Major Risk Factor for Arterial Thrombotic Disease. British Journal of Hematology 99: 304-307, 1997.
Zivelin A, Rosenberg N, Faier S et al. A Single Genetic Origin for
the Common Prothrombotic G20210A Polymorphism in the Prothrombin Gene. Blood 92: 1119-1124, 1998.
Ferrasei P, Marchetti G, Legnani C et al. The Heterozygous 20210 G/A Prothrombin Genotype is Associated with Early Venous Thrombosis in Inherited Thrombophilias and is not Increased in Frequency in Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology 17: 2418-2422, 1997.
Poort SR, Rosendaal FR, Reistsma PH et al. A Common Genetic Variation in the 3’-Untranslated Region of the Prothrombin Gene is Associated with Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood 88: 3698-3703, 1996.
Franco RF, Trip MD, Ten Cate H et al. The 20210 G->A Mutation in the 3’-untranslated Region of the Prothrombin Gene and the Risk for Arterial Thrombotic Disease. British Journal of Hematology 104: 50-54, 1999.
Croft SA, Daly ME, Steeds RP et al. The Prothrombin 20210A Allele and Its Association with Myocardial Infarction. Thrombosis Haemostasis 81: 861-864, 1999.
Doggen CJM, Manger Cats V, Bertina RM, et al. Interaction of coagulation defects and cardiovascular risk factors. Increased risk of Myocardial Infarction associated with factor V Leiden or prothrombin 20210A. Circulation 9: 1037-1041, 1998.
Rosendaal FR, Siscovick DS, Schwartz SM, et al. A Common Prothrombin Variant (20210 G to A) Increases the Risk of Myocardial Infarction in Young Women. Blood 90: 1747- 1750,1997.
Poort SR, Bertina RM, Vos HL. Rapid Detection of the Prothrombin 20210 A Variation by Allele Specific PCR. Thrombosis Haemostasis. 78: 1157-1158, 1997
Rosendaal FR, Doggen CJM, Zivelin A, et al. Geographic Distribution of the 20210 G to A Prothrombin Variant. Thrombosis Haemostasis. 79: 706-708, 1998
Inbal A, Freimark D, Modan B et al. Synergistic Effects of Prothrombotic Polymorphisms and Atherogenic Factors on the Risk of Myocardial Infarction in Young Males. Blood 93: 2186- 2190, 1999.
Kim RJ, Becker RC. Association Between Factor V Leiden, Prothrombin G20210A and Methylenetetrahydrofolate Reductase C677T Mutations and Events of the Arterial Circulatory Systems: A Meta-Analysis of published Studies. American Heart Journal 146: 948-955, 2003.
Burzotta F, Paciaroni K, Stefano VD et al. Increased Prevelance of the G20210A Prothrombin Gene Variant in Acute Coronary Syndromes Without Metabolic or Acquired Risk Factors or with Limited Extent of Disease. European Heart Journal 23: 26-30, 2002.